It will be much more than 20 million, but it wont go over 100million. I say about 50-60Million first year and Elite will probably get about 40Million of that profit first year. The big news in my opinion that the market is waiting to hear, is the validation of the plug and play system. If indeed, eli 201 and 202 doesnt need anymore trials or HAL studies, that would be huge and the market will react accordingly. I still question the retail size of the otc market to be able to drive it over 1 billion. We need big institutional investors and they wont come until an uplisting is made and we get into multiple dollars to at least qualify for the AMEX. If the plug and play works, time and cost is gone and would be huge news for the market, because then it could be instant FDA approved ADTs being poured into the marketplace.
To me, the ELI200 approval would validate Elite, but the plug and play nature without having to do trials would validate the tech to the point where the market cap would easily then go into the billions, but only after they uplist.
This is why Im all for a reverse split, but only after ELI200 launches and the plug and play tech is validated where FDA says no more trials are needed to bring the rest of the ADT pipeline to fruition
News 
Market Data 
Discover 
